BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 37705051)

  • 1. Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.
    Amiri M; Molavi O; Sabetkam S; Jafari S; Montazersaheb S
    Cancer Cell Int; 2023 Sep; 23(1):200. PubMed ID: 37705051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy.
    Sansone C; Bruno A; Piscitelli C; Baci D; Fontana A; Brunet C; Noonan DM; Albini A
    Cells; 2021 Jan; 10(2):. PubMed ID: 33504012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural compound inducers of immunogenic cell death.
    Diederich M
    Arch Pharm Res; 2019 Jul; 42(7):629-645. PubMed ID: 30955159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromomycin A
    Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
    Front Immunol; 2022; 13():941757. PubMed ID: 36439184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural modulators of the hallmarks of immunogenic cell death.
    Radogna F; Dicato M; Diederich M
    Biochem Pharmacol; 2019 Apr; 162():55-70. PubMed ID: 30615863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory DAMPs in immunogenic cell death and its clinical implications.
    Hayashi K; Nikolos F; Chan KS
    Cell Stress; 2021 Mar; 5(4):52-54. PubMed ID: 33821233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome.
    Lamberti MJ; Nigro A; Casolaro V; Rumie Vittar NB; Dal Col J
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic cell death in cancer therapy: Present and emerging inducers.
    Zhou J; Wang G; Chen Y; Wang H; Hua Y; Cai Z
    J Cell Mol Med; 2019 Aug; 23(8):4854-4865. PubMed ID: 31210425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marine natural product lepadin A as a novel inducer of immunogenic cell death via CD91-dependent pathway.
    Carbone D; Gallo C; Nuzzo G; Barra G; Dell'Isola M; Affuso M; Follero O; Albiani F; Sansone C; Manzo E; d'Ippolito G; Fontana A
    Nat Prod Bioprospect; 2023 Oct; 13(1):34. PubMed ID: 37779162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress in inducing immunogenic cell death of tumor cells.
    Xie D; Wang Q; Wu G
    Front Immunol; 2022; 13():1017400. PubMed ID: 36466838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
    Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
    Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics.
    Garg AD; More S; Rufo N; Mece O; Sassano ML; Agostinis P; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2017; 6(12):e1386829. PubMed ID: 29209573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Blockade of Mitogen-Activated Protein Kinase 14 Activation by Marine Natural Product Crassolide Triggers ICD in Tumor Cells and Stimulates Anti-Tumor Immunity.
    Tsai KC; Chen CS; Su JH; Lee YC; Tseng YH; Wei WC
    Mar Drugs; 2023 Mar; 21(4):. PubMed ID: 37103364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor.
    Jiang Q; Zhang C; Wang H; Peng T; Zhang L; Wang Y; Han W; Shi C
    Front Oncol; 2019; 9():1196. PubMed ID: 31781498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.